About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UNKNOWNPhase 2

A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma

A 12-week Randomized, Double-blind, Parallel Group, Placebo-controlled Dose Range Finding Study to Evaluate the Efficacy of Oglemilast in the Treatment of Stable Mild to Moderate Persistent Asthma

NCT00859404•Glenmark Pharmaceuticals Europe Ltd. (R&D)

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Asthma

Interventions

oglemilast

Locations

1

India

Locations (1)

Glenmark investigational sites (28)

Mumbai, Bangalore Etc, India

Key Dates

Start Date

October 1, 2008

Primary Completion Date

December 1, 2009

Completion Date

January 1, 2010

Last Updated

September 24, 2009

Related Studies

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

NCT07486401

Asthma ExacerbationsBiomarkers / Blood+1 more

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

NCT02327897

RECRUITINGPhase 2

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

NCT07219173

Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma

NCT04706988

To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong

NCT04639791

RECRUITINGPhase 3

A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma

NCT06471257

View all related studies

Sponsors

Lead Sponsor

Glenmark Pharmaceuticals Europe Ltd. (R&D)

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 24, 2009Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions